International Patent: HETEROCYCLIC COMPOUNDS MODULATING THE NLRP3 INFLAMMASOME PATHWAY

GENEVA, July 2 -- AC IMMUNE SA filed a patent application (EP2025/088512) for “HETEROCYCLIC COMPOUNDS MODULATING THE NLRP3 INFLAMMASOME PATHWAY”. With publication no. WO/2026/132518, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61P 3/10

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....